Clinical trial
A Non-interventional Observational Post Authorization Study to Assess Safety and Outcome of the Various Medication Usage Patterns in Clinical Routine Practice in Patients Receiving Lenalidomide (REVIEW)
NCT02528838 is registered in ClinicalTrials.gov with Celgene as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Non-interventional Observational Post Authorization Study to Assess Safety and Outcome of the Various Medication Usage Patterns in Clinical Routine Practice in Patients Receiving Lenalidomide (REVIEW)
- Lead sponsor
- Celgene
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 1, 2011
- Completion date
- January 15, 2018
- Enrollment
- 238 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.